Metronidazole Mercury Pharmaceuticals

Metronidazole, the active ingredient in Metronidazole Mercury Pharmaceuticals, is a nitroimidazole presented as a topical formulation for skin use. It is employed to manage certain bacterial and protozoal skin conditions, particularly in adult patients with rosacea, acne vulgaris, or other dermatologic infections.

GNH USA supplies Metronidazole Mercury Pharmaceuticals as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides reliable global distribution.

Metronidazole is a nitroimidazole antimicrobial used topically for several dermatologic conditions.

- Rosacea: reduces inflammatory lesions and erythema, improving skin appearance. - Acne vulgaris: decreases bacterial colonisation and inflammation, leading to fewer pimples. - Dermatologic infections: treats susceptible bacterial or protozoal skin infections, promoting lesion resolution.

Topical metronidazole may cause local and systemic adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Skin irritation: redness, itching or burning at the application site. - Dryness: localized skin dryness or flaking. - Pruritus: mild itching. - Contact dermatitis: allergic skin reaction.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, hives, or difficulty breathing. - Stevens‑Johnson syndrome: rare severe skin blistering. - Neurotoxicity: rare peripheral neuropathy or dizziness.

When using topical metronidazole, consider the following safety measures.

- Pregnancy: safety not established; use only if benefits outweigh risks. - Breastfeeding: may be excreted in milk; consult a healthcare professional. - Liver disease: monitor because the drug is metabolised hepatically. - Alcohol consumption: avoid excessive intake as it may increase side effects. - Sun exposure: may increase skin sensitivity; use sunscreen. - Store below 25°C: keep in original container, protect from moisture and light.

Metronidazole can interact with several medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - Alcohol: may cause a disulfiram‑like reaction with flushing and nausea. - Warfarin: may enhance anticoagulant effect, increasing bleeding risk. - Lithium: may raise lithium levels, risking toxicity.

Moderate Interactions (Monitor Closely): - Phenytoin: may reduce metronidazole levels, decreasing efficacy. - Cimetidine: may increase metronidazole plasma concentration. - Oral contraceptives: may have reduced effectiveness; consider alternative contraception.